Posted on 10/16/2014 8:21:26 AM PDT by SeekAndFind
Israeli drug companies, such as Teva, are pretty good at producing imitation drugs quickly. Teva was truly disruptive to big pharma companies, since they often feared blockbuster drugs going off patent as Teva was ready and waiting with a quality generic imitation.
It’s not so surprising that what is bad for big pharma is good for the patient and the consumer, and now an Israeli biotech company named Protalix is ready to replenish supplies of the experimental Ebola vaccine, ZMapp.
The disease has already claimed the lives of 3,944, predominantly in Africa, but in the U.S., there has been one casualty and another one infected. The World Health Organization hoped to have a vaccine by November, but even if ZMapp can be available by the target date, supplies will be insufficient to meet requirements. However, the Times of Israel reports that Protalix can step in and produce as much ZMapp as is needed. In an interview with Channel 2, executive vice president of research and development at Protalix, Yossie Shaaltiel, said, “Today, our production capacity exceeds our needs, and we would certainly be happy to have our company produce the Ebola drug for them. We know how to do it effectively, in large quantities and in a relatively short period of time.”
I have a feeling BDS is going to be strangely silent about this outrage.
-— There is no vaccine. -—
Glaxo has one in Phase 2 trials in West Africa. 10,000 doses are projected to be ready in 6 months.
Nonsense. Serum therapy has a valid immune mechanism underlying it and continues to be evaluated for efficacy.
We’ll take 330 million, please.
In Mali, GlaxoSmithKline has teamed up with the Center for Vaccine Development of Mali and the Ministry of Health of Mali to administer its cAd3-ZEBOV vaccine to a total of 40 healthcare workers. Glaxo has been working with the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases on its jab, which uses a chimpanzee cold virus vector containing two ebolavirus gene segments that switch on a protein to activate an immune response in the body. A parallel trial in Gambia is expected to begin soon.
There are no natural resources. Only what creative people can do with what is all around them.
They stopped blaming it on mad Joooo! scientists. It offended the vast majority of the Democrats (the mentally ill). But they can still blame Ebola on Joooo! scientists! Just not mad ones.
HOW I EDITED AN AGRICULTURAL PAPER ONCE.
by Mark Twain, The Galaxy, July, 1870
http://www.twainquotes.com/Galaxy/187007a.html
Thanks SeekAndFind.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.